Former Professor Embroiled in Stem Cell Paper Fabrication Scandal Acquires UAE Citizenship, Loses South Korean Nationality
Published
According to the South Korean newspaper Hankyoreh, Hwang Woo-suk, the former Seoul National University professor who became embroiled in controversy over fabricating stem cell papers, has acquired citizenship of the United Arab Emirates (UAE) and lost his South Korean nationality. It is reported that Hwang is currently serving as CEO (Chief Executive Officer) of a company that creates animal clones.
Hwang was found to have falsified data in a paper on human embryonic stem cells that he published in the mid-2000s. Because of this problem, Hwang left the university and drew significant attention in the world of research. Debate over the reliability of research has continued for a long time in South Korea.
This report does not reveal detailed circumstances, such as when or why Hwang changed his nationality. Nor does it provide detailed information at this time about the business activities of the company he is newly involved with or his future activities.
For readers in Japan as well, this is a topic that prompts reflection on the challenges faced by researchers who work across national borders and on the importance of protecting the accuracy and credibility of research results. Attention is focused on further reports to come.
Sources: ハンギョレ新聞
More Japan news
- Toyota, Nissan and Honda to Hold Engineer Event in Fiscal 2026 Under the Theme of “AI”
- HTC NIPPON Promotes Business Use of the Smart Glasses "VIVE Eagle" as Sponsor of Remote Guidance App Exhibition
- Defense-Related ETF "GX Defense Tech" Publishes Stock Price Information; Detailed News Not Available
- U.S. Ambassador to South Korea Marks 100 Days in Office, Stresses the Importance of Protecting Trust Between South Korea and the United States
- South Korean National Assembly Passes Special Counsel Act to Investigate "Fabricated Indictments"
- Foreign Minister Motegi Holds Talks with Foreign Ministers of France, Italy and the UK, Calls for Appropriate Response on EU Exclusion of Japanese-Made EVs from Preferential Treatment
- Health Drink Market in Japan Set to Grow, Driven by Aging Population and Health Consciousness
- National Health Insurance Premium Cap to Rise by 30,000 Yen in FY2027, Targeting High Earners